AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14964629 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 294
Study 11313170 — intervention group
Group type: EXPERIMENTAL
Intervention: L-758,298 (60 or 100 mg)
Number of subjects: 53
Study 11313170 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (32 mg)
Number of subjects: 53
Study 9390601 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 70 microg/kg over 10 min before surgical incision
Number of subjects: 38
Study 9390601 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil 70 microg/kg over 10 min after incision
Number of subjects: 38
Study 8198929 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally applied morphine at 100 ng ml‐1
Number of subjects: 0
Study 8198929 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally applied morphine at 100 micrograms ml‐1
Number of subjects: 0
Study 8198929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3332675 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir 3% ointment and vidarabine 3% ointment
Number of subjects: 32
Study 3332675 — intervention group
Group type: COMPARATOR
Intervention: Acyclovir 3% ointment and placebo
Number of subjects: 32
Study 31980993 — intervention group
Group type: COMPARATOR
Intervention: Dapivirine vaginal ring
Number of subjects: 0
Study 31980993 — intervention group
Group type: COMPARATOR
Intervention: External peers
Number of subjects: 0
Study 29555393 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine measurements on days 1, 3, and 5
Number of subjects: 181
Study 26744232 — intervention group
Group type: EXPERIMENTAL
Intervention: smartcare
Number of subjects: 0
Study 26744232 — intervention group
Group type: EXPERIMENTAL
Intervention: smartcare plus financial incentives
Number of subjects: 0
Study 26744232 — intervention group
Group type: COMPARATOR
Intervention: control (standard basic education)
Number of subjects: 0
Study 23886401 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-supported internet-based intervention
Number of subjects: 62
Study 23886401 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face intervention
Number of subjects: 62
Study 22666758 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal root ganglion destruction by adriamycin
Number of subjects: 72
Study 22666758 — intervention group
Group type: COMPARATOR
Intervention: Injection (control group)
Number of subjects: 72
Study 19913781 — intervention group
Group type: EXPERIMENTAL
Intervention: Online cognitive behavioral therapy (CBT)
Number of subjects: 263
Study 19913781 — intervention group
Group type: EXPERIMENTAL
Intervention: Online problem-solving therapy (PST)
Number of subjects: 263
Study 19913781 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 263
Study 18076238 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-load squat intervention set (40% of 1RM)
Number of subjects: 30
Study 18076238 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy-load squat intervention set (80% of 1RM)
Number of subjects: 30
Study 18076238 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 30
Study 16364838 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 50 mg/day
Number of subjects: 69
Study 16364838 — intervention group
Group type: COMPARATOR
Intervention: Bendroflumethiazide 2.5 mg/day
Number of subjects: 69
Study 16364838 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 50 mg/day (for resistant hypertension)
Number of subjects: 69
Study 11850256 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin 5 to 100 mg (single-dose)
Number of subjects: 34
Study 11850256 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin 15 mg daily (multiple-dose)
Number of subjects: 34
Study 11850256 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin 50 mg daily (multiple-dose)
Number of subjects: 34
Study 11850256 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin 70 mg daily (multiple-dose)
Number of subjects: 34
Study 11850256 — intervention group
Group type: COMPARATOR
Intervention: Caspofungin 50 mg daily without loading dose (multiple-dose)
Number of subjects: 34
Study 11850256 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin 70 mg daily (3-week study)
Number of subjects: 34
Study 10592855 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclofem
Number of subjects: 2252
Study 10592855 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesigyna
Number of subjects: 2252
Study 8572837 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of losartan potassium and 12.5 mg of hydrochlorothiazide
Number of subjects: 703
Study 8572837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 703
Study 1956528 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte solution 2 (CE2)
Number of subjects: 0
Study 1956528 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavored water placebo
Number of subjects: 0
Study 1956528 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate-electrolyte solution 1 (CE1)
Number of subjects: 0
Study 1956528 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 0
Study 6129886 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-selective beta-adrenoceptor blocker propranolol
Number of subjects: 17
Study 6129886 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective beta-adrenoceptor blocker metoprolol
Number of subjects: 17
Study 6129886 — intervention group
Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 17
Study 31248962 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprasternal palpation of the ETT tip
Number of subjects: 118
Study 31248962 — intervention group
Group type: COMPARATOR
Intervention: Weight-based estimation (insertion depth (cm)=6 + wt (kg))
Number of subjects: 118
Study 31050931 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL) treatment
Number of subjects: 40
Study 28941948 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week inter-donation interval (men)
Number of subjects: 45042
Study 28941948 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week inter-donation interval (men)
Number of subjects: 45042
Study 28941948 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week inter-donation interval (women)
Number of subjects: 45042
Study 28941948 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-week inter-donation interval (women)
Number of subjects: 45042
Study 28941948 — intervention group
Group type: COMPARATOR
Intervention: More frequent donation (compared to standard frequency groups)
Number of subjects: 45042
Study 28941948 — intervention group
Group type: COMPARATOR
Intervention: Standard frequency groups (12-week for men, 16-week for women)
Number of subjects: 45042
Study 26049533 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person intervention
Number of subjects: 494
Study 26049533 — intervention group
Group type: EXPERIMENTAL
Intervention: Take-home booklet intervention
Number of subjects: 494
Study 26049533 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic interactive tablet intervention
Number of subjects: 494
Study 26049533 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual control
Number of subjects: 494
Study 24680587 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI <25
Number of subjects: 2596
Study 24680587 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥40
Number of subjects: 2596
Study 24680587 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 2596
Study 24680587 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 2596
Study 24680587 — intervention group
Group type: EXPERIMENTAL
Intervention: Race
Number of subjects: 2596
Study 24680587 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk group
Number of subjects: 2596
Study 22031171 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 or 20 mg/day depending on weight)
Number of subjects: 221
Study 22031171 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study 19539430 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum chemotherapy regimens
Number of subjects: 683
Study 19539430 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxane chemotherapy regimens
Number of subjects: 683
Study 19539430 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of platinum and taxane chemotherapy regimens
Number of subjects: 683
Study 19539430 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with an agent other than platinum or taxane
Number of subjects: 683
Study 17855199 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic radial artery harvesting (group A)
Number of subjects: 50
Study 17855199 — intervention group
Group type: COMPARATOR
Intervention: Conventional radial artery harvesting (group B)
Number of subjects: 50
Study 14678347 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (1200 microg)
Number of subjects: 16
Study 12231083 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide 40 mg once daily
Number of subjects: 24
Study 12231083 — intervention group
Group type: COMPARATOR
Intervention: Captopril 6.25 mg twice daily
Number of subjects: 24
Study 12231083 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide 40 mg once daily (2-week treatment)
Number of subjects: 24
Study 12231083 — intervention group
Group type: COMPARATOR
Intervention: Captopril 12.5 mg twice daily (2-week treatment)
Number of subjects: 24
Study 9844955 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol treatment
Number of subjects: 0
Study 9844955 — intervention group
Group type: COMPARATOR
Intervention: Drug-free condition
Number of subjects: 0
Study 8008342 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil (5-FU) injections (5 mg, five injections over 2 weeks post-surgery)
Number of subjects: 62
Study 8008342 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil (5-FU) injections
Number of subjects: 62
Study 8008342 — intervention group
Group type: COMPARATOR
Intervention: Control (no injections)
Number of subjects: 62
Study 2937740 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (OFX) for 10 days
Number of subjects: 20
Study 2937740 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CPX) for 10 days
Number of subjects: 20
Study 30261617 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Oleic Acid meal
Number of subjects: 8
Study 30261617 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Linoleic Acid meal
Number of subjects: 8
Study 30261617 — intervention group
Group type: COMPARATOR
Intervention: High-Carbohydrate Control meal
Number of subjects: 8
Study 27797248 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical resection 6-8 weeks after neoadjuvant CRT
Number of subjects: 0
Study 27797248 — intervention group
Group type: COMPARATOR
Intervention: Surgical resection 9-14 weeks after neoadjuvant CRT
Number of subjects: 0
Study 24549160 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium bromide (18 μg) once daily inhaled capsule
Number of subjects: 839
Study 24549160 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 839
Study 21986341 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (CR) intervention comprising 12 individual weekly sessions
Number of subjects: 201
Study 21986341 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 201
Study 20301228 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-led teaching
Number of subjects: 42
Study 20301228 — intervention group
Group type: COMPARATOR
Intervention: Doctor-led teaching
Number of subjects: 42
Study 20301228 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge test
Number of subjects: 42
Study 18574929 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy for early stage patients
Number of subjects: 60
Study 18574929 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiparkinsonian therapy for late stage patients
Number of subjects: 60
Study 18574929 — intervention group
Group type: COMPARATOR
Intervention: Normal healthy controls
Number of subjects: 60
Study 19127915 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Zhongwan (CV 12), Tianshu (ST 25), Guanyuan (CV 4) combined with diet control
Number of subjects: 334
Study 19127915 — intervention group
Group type: COMPARATOR
Intervention: Simple acupuncture
Number of subjects: 334
Study 19127915 — intervention group
Group type: COMPARATOR
Intervention: Diet control
Number of subjects: 334
Study 19127915 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation group and control group I
Number of subjects: 334
Study 19127915 — intervention group
Group type: COMPARATOR
Intervention: Control group II
Number of subjects: 334
Study 15160570 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical placental extract
Number of subjects: 100
Study 15160570 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 100
Study 11219875 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonates
Number of subjects: 0
Study 11219875 — intervention group
Group type: COMPARATOR
Intervention: Conventional analgesic management
Number of subjects: 0
Study 9341696 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of carotid artery IMT
Number of subjects: 202
Study 9341696 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-detected carotid atherosclerosis
Number of subjects: 202
Study 9341696 — intervention group
Group type: EXPERIMENTAL
Intervention: Associations with IMT
Number of subjects: 202
Study 8476402 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group treatment
Number of subjects: 67
Study 8476402 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment control
Number of subjects: 67
Study 2878389 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 10 mg
Number of subjects: 24
Study 2878389 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 24
Study 2878389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 30736918 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (VR)
Number of subjects: 60
Study 30736918 — intervention group
Group type: EXPERIMENTAL
Intervention: Photo-enhanced Imaginative (PIC)
Number of subjects: 60
Study 30736918 — intervention group
Group type: COMPARATOR
Intervention: Neutral condition (no contextual exposure)
Number of subjects: 60
Study 29952641 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.04 mg/kg) with propofol
Number of subjects: 56
Study 29952641 — intervention group
Group type: COMPARATOR
Intervention: Propofol alone
Number of subjects: 56
Study 27289438 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care (POC) electrolyte testing
Number of subjects: 225
Study 27289438 — intervention group
Group type: COMPARATOR
Intervention: Traditional serum chemistry testing
Number of subjects: 225
Study 24937017 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated, data-driven, electronic health record-embedded program to identify patients due for colorectal screening and mail FIT kits with pictographic instructions; improvement process (Plan-Do-Study-Act) to enhance adoption and effectiveness.
Number of subjects: 26
Study 24937017 — intervention group
Group type: COMPARATOR
Intervention: Opportunistic colorectal-cancer screening provided at clinic visits.
Number of subjects: 26
Study 21163585 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser (LLL) therapy 2.5 J/cm(2)
Number of subjects: 75
Study 21163585 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser
Number of subjects: 75
Study 19223151 — intervention group
Group type: EXPERIMENTAL
Intervention: 10.8mg yohimbine hydrochloride
Number of subjects: 24
Study 19223151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 17698433 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture for 8 weeks
Number of subjects: 118
Study 17698433 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (non-smoking-cessation-related acupoints) for 8 weeks
Number of subjects: 118
Study 17698433 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Number of subjects: 118
Study 15356829 — intervention group
Group type: EXPERIMENTAL
Intervention: Amprenavir-ritonavir (APV-RTV) 600/100 mg b.i.d.
Number of subjects: 0
Study 15356829 — intervention group
Group type: EXPERIMENTAL
Intervention: Amprenavir-ritonavir (APV-RTV) 1200/200 mg q.d.
Number of subjects: 0
Study 15356829 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens (APV-RTV 600/100 mg b.i.d. and APV-RTV 1200/200 mg q.d.)
Number of subjects: 0
Study 11855793 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (5 mg daily)
Number of subjects: 34
Study 11855793 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg daily)
Number of subjects: 34
Study 11855793 — intervention group
Group type: EXPERIMENTAL
Intervention: Both enalapril and losartan
Number of subjects: 34
Study 9926292 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C 5g daily for 4 weeks
Number of subjects: 60
Study 9926292 — intervention group
Group type: COMPARATOR
Intervention: Antacids for 4 weeks (Control)
Number of subjects: 60
Study 7529856 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative Gleason score
Number of subjects: 124
Study 7529856 — intervention group
Group type: EXPERIMENTAL
Intervention: HER-2/neu antigenicity
Number of subjects: 124
Study 7529856 — intervention group
Group type: EXPERIMENTAL
Intervention: CAS-200 DNA ploidy
Number of subjects: 124
Study 7529856 — intervention group
Group type: EXPERIMENTAL
Intervention: Twelve Markovian nuclear texture and shape features
Number of subjects: 124
Study 7529856 — intervention group
Group type: EXPERIMENTAL
Intervention: PCNA
Number of subjects: 124
Study 7529856 — intervention group
Group type: EXPERIMENTAL
Intervention: Best Markovian features combined with post-operative Gleason score
Number of subjects: 124
Study 2831525 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of enalapril
Number of subjects: 58
Study 2831525 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of atenolol
Number of subjects: 58
Study 2831525 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of enalapril (after dosage increase)
Number of subjects: 58
Study 2831525 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of atenolol (after dosage increase)
Number of subjects: 58
Study 31990730 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum chewing for 2 minutes before induction of anesthesia (group G)
Number of subjects: 140
Study 31990730 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C) asked to swallow twice without additional treatment
Number of subjects: 140
Study 31990730 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum chewing (group G)
Number of subjects: 140
Study 31990730 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum chewing (group G) in patients with bloody SGA devices
Number of subjects: 140
Study 31990730 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C) in patients with bloody SGA devices
Number of subjects: 140
Study 31990730 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum chewing (group G) in patients without bloody SGA devices
Number of subjects: 140
Study 31990730 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C) in patients without bloody SGA devices
Number of subjects: 140
Study 29358539 — intervention group
Group type: EXPERIMENTAL
Intervention: 625 mg of combined amoxicillin and clavulanic acid tablet
Number of subjects: 60
Study 29358539 — intervention group
Group type: EXPERIMENTAL
Intervention: 625 mg of combined amoxicillin and clavulanic acid tablet + 400 mg metronidazole tablet
Number of subjects: 60
Study 29358539 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 60
Study 27241670 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual aspiration (group 1)
Number of subjects: 220
Study 27241670 — intervention group
Group type: COMPARATOR
Intervention: Wall suction (group 2)
Number of subjects: 220
Study 27241670 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 220
Study 25596929 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention program for children exposed to IPV
Number of subjects: 120
Study 25596929 — intervention group
Group type: COMPARATOR
Intervention: Waitlist comparison condition
Number of subjects: 120
Study 22984173 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab 50 mg
Number of subjects: 316
Study 22984173 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab 100 mg
Number of subjects: 316
Study 22984173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 316
Study 20837926 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 100
Study 20837926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 18412944 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS treatment (1 Hz for 2 weeks)
Number of subjects: 150
Study 18412944 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS treatment
Number of subjects: 150
Study 16485876 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with topical 5‐aminolevulinic acid (ALA), treated 4 times weekly with 30‐minute ALA incubation and blue light activation.
Number of subjects: 21
Study 16485876 — intervention group
Group type: COMPARATOR
Intervention: Topical clindamycin, used as control treatment.
Number of subjects: 21
Study 16485876 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient satisfaction for ALA PDT-treated side.
Number of subjects: 21
Study 11979068 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of caffeine
Number of subjects: 10
Study 11979068 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 10426835 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory intermittent dobutamine infusion at 2.5 microgram/kg/min for 48 hours/week for 6 months
Number of subjects: 38
Study 10426835 — intervention group
Group type: COMPARATOR
Intervention: Optimal standard treatment (control group)
Number of subjects: 38
Study 7560119 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.1 mg/kg
Number of subjects: 34
Study 7560119 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.3 mg/kg
Number of subjects: 34